News | January 06, 2024
Supriya Lifesciences received GMP certification from ANVISA Brazil
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
Investment is additive to KKR’s existing health care growth strategy
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Subscribe To Our Newsletter & Stay Updated
